July 31, 2024Open Access

MEST C Score and Treatment Response in IgA Nephropathy in a Tertiary Care Hospital: A Descriptive Cross-sectional Study

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

IgA nephropathy is the leading cause of primary glomerulonephritis worldwide. The Oxford classification can predict IgA nephropathy prognosis through renal biopsy however its applicability to the Nepalese population remains unexplored. This study aimed to evaluate the MEST-C score and treatment response in patients with IgA nephropathy.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Thapa et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5e5c4b6db64358757abb6 https://doi.org/https://doi.org/10.31729/jnma.8707

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial2008 · 239 citations
2The incidence of primary glomerulonephritis worldwide: a systematic review of the literature2010 · 732 citations
3Impact of Early Proteinuria Reduction in Glomerular Disease and Decline of Kidney Function: A Retrospective Cohort2022 · 8 citations
4Hisopathological spectrum of glomerular disease in nepal: a seven-year retrospective study.2008 · 30 citations
5IgA Nephropathy: Core Curriculum 20212021 · 332 citations

Me gusta

Guardar

Ver artículo completo